Metemis Development logo — Empowering customers with advanced diagnostic solutions deri...

Metemis Development

Empowering customers with advanced diagnostic solutions derived from extensive research and expertise in electrochemical measurement.

Founded 2014 Grant Total: $50.00K Biotechnology, Design +1

General Information

Company Name Metemis Development
Founded Year 2014
Industries Biotechnology, Design, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Metemis Development. To contact Metemis Development, visit metemis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Metemis Development compare?

A PDF of Metemis Development and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Metemis Development soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Metemis Development

Metemis Development is a biotechnology startup based in Evry, France, established in 2014. The company's slogan "Empowering customers with advanced diagnostic solutions derived from extensive research and expertise in electrochemical measurement" reflects its focus on leveraging electrochemical measurement for advanced diagnostic solutions. Metemis emphasizes the development of high-quality products, particularly in the field of medical devices, through rigorous research and expertise in electrochemical measurement in liquid mediums. One of their notable achievements is the creation of a rapid diagnostic test for malaria, which incorporates advanced detection technology and novel infection biomarkers. This innovative approach has the potential to significantly improve the speed and accuracy of malaria diagnosis. Metemis received a €50.00K grant investment on 01 December 2014 from EASME - EU Executive Agency for SMEs, highlighting its ability to attract support from reputable funding sources. This investment indicates external validation of the company's potential and the relevance of its technology in addressing critical healthcare challenges. Overall, Metemis Development's focus on technological innovation and healthcare solutions positions it as a promising player in the biotechnology industry.

Business keywords: diagnostic solutions, electrochemical measurement, biomarker detection, rapid diagnostic test, malaria detection, liquid mediums

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Dec 2014

Metemis Development Alternatives & Competitors

View All Alternatives
Metemis Development vs

Introducing a groundbreaking rapid test for malaria detection – an effortless, painless solution pro...

Seed
Biotechnology, Health Care
Metemis Development vs

Creating precise measurements for diagnoses and food safety inspections through advanced electrochem...

Series B
Biotechnology, Medical Devices
Metemis Development vs
Mellitus, LLC
Mellitus, LLC United States

Mellitus developed a simple diagnostic test for gestational diabetes-Work continues at Harvard/MassG...

5 employees
Biotechnology, Health Care

FAQ About Metemis Development

Empowering customers with advanced diagnostic solutions derived from extensive research and expertise in electrochemical measurement.
Metemis Development was founded in 2014.
Metemis Development operates in Biotechnology, Design and Medical Devices. Its work centres on diagnostic solutions, electrochemical measurement, biomarker detection and rapid diagnostic test.
Metemis Development has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Grant.
Top alternatives and competitors to Metemis Development include Fyodor Biotechnologies, IMMUNOSENS, Mellitus, LLC, Medical Diagnostech (Pty) Ltd, HueDx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Metemis Development and Fyodor Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Metemis Development, https://bouncewatch.com/company/metemis-development, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes